经鼻内镜术中脑脊液漏的分级重建策略(一到二级脑脊液漏:术区原位取材重建;二到三级脑脊液漏:骨瓣筋膜交叉嵌入技术)

注册号:

Registration number:

ChiCTR2100044764 

最近更新日期:

Date of Last Refreshed on:

2021-10-18 00:07:44 

注册时间:

Date of Registration:

2021-03-27 00:00:00 

注册号状态:

补注册

Registration Status:

Retrospective registration

注册题目:

经鼻内镜术中脑脊液漏的分级重建策略(一到二级脑脊液漏:术区原位取材重建;二到三级脑脊液漏:骨瓣筋膜交叉嵌入技术)

Public title:

Reconstruction Strategy of Cerebral Spinal Fluid Leak during Endoscopic Endonasal Surgery (Grade I-II: in Situ Material Harvest for Reconstruction; Grade II-III: Cruciate Embedding Fascia-Bone Flap Technique)

注册题目简写:

English Acronym:

研究课题的正式科学名称:

经鼻内镜术中脑脊液漏的分级重建策略(一到二级脑脊液漏:术区原位取材重建;二到三级脑脊液漏:骨瓣筋膜交叉嵌入技术)

Scientific title:

Reconstruction Strategy of Cerebral Spinal Fluid Leak during Endoscopic Endonasal Surgery (Grade I-II: in Situ Material Harvest for Reconstruction; Grade II-III: Cruciate Embedding Fascia-Bone Flap Technique)

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

赵文吉 

研究负责人:

王晓澍 

Applicant:

Zhao Wenji 

Study leader:

Wang Xiaoshu 

申请注册联系人电话:

Applicant telephone:

+86 15310943820

研究负责人电话:

Study leader's
telephone:

+86 13983762659

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

wjzhao950210@outlook.com

研究负责人电子邮件:

Study leader's E-mail:

xswang789@cqmu.edu.cn

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

中国重庆市渝中区友谊路1号

研究负责人通讯地址:

中国重庆市渝中区友谊路1号

Applicant address:

1 Youyi Road, Yuzhong District, Chongqing, China.

Study leader's address:

1 Youyi Road, Yuzhong District, Chongqing, China.

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

重庆医科大学附属第一医院神经外科

Applicant's institution:

Department of Neurosurgery, The First Affiliated Hospital of Chongqing Medical University

研究负责人所在单位:

重庆医科大学附属第一医院神经外科

Affiliation of the Leader:

Department of Neurosurgery, The First Affiliated Hospital of Chongqing Medical University

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2021-036

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

重庆医科大学附属第一医院伦理委员会

Name of the ethic committee:

Ethics Committee of the First Affiliated Hospital of Chongqing Medical University

伦理委员会批准日期:

Date of approved by ethic committee:

2021-02-09 00:00:00

伦理委员会联系人:

郭建明

Contact Name of the ethic committee:

Guo Jianming

伦理委员会联系地址:

中国重庆市渝中区友谊路1号重庆医科大学附属第一医院

Contact Address of the ethic committee:

The First Affiliated Hospital of Chongqing Medical University, 1 Youyi Road, Yuzhong District, Chongqing, China.

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 23 89011876

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

重庆医科大学附属第一医院

Primary sponsor:

The First Affiliated Hospital of Chongqing Medical University

研究实施负责(组长)单位地址:

中国重庆市渝中区友谊路1号

Primary sponsor's address:

1 Youyi Road, Yuzhong District, Chongqing, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

重庆

市(区县):

Country:

China

Province:

Chongqing

City:

单位(医院):

重庆医科大学附属第一医院

具体地址:

渝中区友谊路1号

Institution
hospital:

The First Affiliated Hospital of Chongqing Medical University

Address:

1 Youyi Road, Yuzhong District.

经费或物资来源:

科室经费

Source(s) of funding:

Department funds

研究疾病:

垂体瘤、颅咽管瘤、脑膜瘤等适合经鼻内镜手术的颅底中线肿瘤  

Target disease:

Pituitary adenomas, craniopharyngiomas, meningiomas and other midline skull base tumors which are suitable forendoscopic endonasal surgery

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

回顾性研究 

Study phase:

Retrospective study

研究设计:

析因分组(即根据危险因素或暴露因素分组) 

Study design:

Factorial 

研究目的:

介绍应用自体骨组织的骨瓣筋膜交叉嵌入法(CEFB)联用鼻中隔带蒂粘膜瓣(PNSF)或不联用鼻中隔带蒂粘膜瓣作为一种颅底重建的方法,并评估其在经鼻内镜手术(EES)术中1~3级脑脊液(CSF)漏的疗效。  

Objectives of Study:

To introduce the cruciate embedding fascia-bone flap (CEFB) as a skull base reconstruction technique using autologous bone flap graft to buttress fascia lata to attach to skull base defect with or without using pedicle vascularized nasoseptal flap (PNSF), and evaluate its efficacy on a consecutive case series of intraoperative grade 1-3 cerebral spinal fluid (CSF) leak in endoscopic endonasal surgery (EES).

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

1.患者合并有其他非颅底中线肿瘤;
2.既往有颅底骨折病史或手术史;
3.患者基础情况差,不能耐受手术者;
4.复发肿瘤患者。

Exclusion criteria:

1. Patient was diagnosed with non-skull base midline tumors;
2. Patient with history of skull base fracture or operation;
4. Patient with poor health condition and could not tolerate the operation;
5. Patient with tumor recurrence.

研究实施时间:

Study execute time:

From 2015-05-01 00:00:00 To 2021-01-10 00:00:00  

征募观察对象时间:

Recruiting time:

From 2015-05-01 00:00:00 To 2020-05-01 00:00:00

干预措施:

Interventions:

组别:

骨瓣筋膜交叉嵌入组

样本量:

110

Group:

Cruciate Embedding Fascia-Bone Flap Technique

Sample size:

干预措施:

干预措施代码:

Intervention:

N/A

Intervention code:

组别:

鼻中隔带蒂粘膜瓣组

样本量:

65

Group:

Pedicle Vascularized Nasoseptal Flap

Sample size:

干预措施:

干预措施代码:

Intervention:

N/A

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

重庆 

市(区县):

 

Country:

China

Province:

Chongqing

City:

单位(医院):

重庆医科大学附属第一医院 

单位级别:

三级甲等 

Institution
hospital:

The First Affiliated Hospital of Chongqing Medical University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

术后脑脊液漏

指标类型:

主要指标

Outcome:

Postoperative cerebrospinal fluid leakagePostoperative CSF leak

Type:

Primary indicator

测量时间点:

测量方法:

坐位观察鼻腔流液情况

Measure time point of outcome:

Measure method:

Observe cerebral spinal fluid in in sitting position

指标中文名:

感染

指标类型:

主要指标

Outcome:

Infection

Type:

Primary indicator

测量时间点:

测量方法:

体温和腰穿脑脊液检查

Measure time point of outcome:

Measure method:

Body temperature and cerebral spinal fluid test

指标中文名:

嗅觉障碍

指标类型:

次要指标

Outcome:

Dysosmia

Type:

Secondary indicator

测量时间点:

测量方法:

询问患者及嗅觉检测

Measure time point of outcome:

Measure method:

Ask patient and smell test

指标中文名:

鼻腔不适感

指标类型:

次要指标

Outcome:

Nasal discomforts

Type:

Secondary indicator

测量时间点:

测量方法:

询问患者和电子鼻咽镜检查

Measure time point of outcome:

Measure method:

Ask patient and nasopharyngoscope

指标中文名:

鼻出血

指标类型:

次要指标

Outcome:

Epistaxis

Type:

Secondary indicator

测量时间点:

测量方法:

观察鼻腔流血情况及鼻内镜检查

Measure time point of outcome:

Measure method:

Observe epistaxis and nasal endoscopy

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

不适用

组织:

不适用

Sample Name:

N/A

Tissue:

N/A

人体标本去向

其它  

说明

不适用

Fate of sample:

0thers  

Note:

N/A

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 22 years
最大 Max age 72 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

不适用

Randomization Procedure (please state who generates the random number sequence and by what method):

N/A

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

N/A

Blinding:

N/A

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

联络通讯作者 请阅读网页注册指南中关于 原始数据共享 的内容。

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Contact the communication author

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

采用Excel数据表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Excel will be used.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2021-03-27 00:04:49